NASDAQ:RAIN

Rain Therapeutics Stock Forecast

etoro logo Buy RAIN
*Your capital is at risk
$2.07
-0.230 (-10.00%)
At Close: Jun 30, 2026
AI Analysis AI Analysis of RAIN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RAIN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for Rain Therapeutics Inc. stock price on Tuesday moving between $1.90 and $2.48
(Updated on Jun 30, 2026)

Sell candidate since Jun 30, 2026

The Rain Therapeutics Inc. stock price fell by -10.00% on the last day (Tuesday, 30th Jun 2026) from $2.30 to $2.07. During the last trading day the stock fluctuated 30.52% from a day low at $1.90 to a day high of $2.48. The price has fallen in 7 of the last 10 days and is down by -9.61% for this period. Volume has increased on the last day by 199 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 282 thousand shares were bought and sold for approximately $583.37 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.29 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -16.99% during the next 3 months and, with a 90% probability hold a price between $0.83 and $1.90 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RAIN Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -15.85%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Rain Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The Rain Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.06 and $2.05. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Rain Therapeutics Inc. stock

Rain Therapeutics Inc. finds support from accumulated volume at $2.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.580 between high and low, or 30.52%. For the last week, the stock has had daily average volatility of 18.39%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAIN) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Rain Therapeutics Inc. to open at $2.15, and during the day (based on 14 day Average True Range), to move between $1.91 and $2.23, which gives a possible trading interval of +/-$0.326 (+/-17.09%) up or down from last closing price. If Rain Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 17.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.06 (0.48%) than the resistance at $2.23 (7.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Rain Therapeutics Inc. stock A Buy?

Rain Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.028 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $2.15 ( 3.86%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RAIN Performance

Trading levels for RAIN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.73 31.88%
R2 2.51 21.18%
R1 2.37 14.56%
Price 2.07
S1 1.93 -6.84%
S2 1.79 -13.45%
S3 1.57 -24.15%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.45 18.36%
R2 2.30 11.11%
R1 2.23 7.73%
Price 2.07
S1 2.06 -0.483%
S2 2.02 -2.42%
S3 2.01 -2.90%

FAQ

What is the symbol for Rain Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Rain Therapeutics Inc. is RAIN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rain Therapeutics Inc. Stock.

What's the current price of Rain Therapeutics Inc. Stock?
As of the end of day on the Jun 30, 2026, the price of an Rain Therapeutics Inc. (RAIN) share was $2.07.

What is the 52-week high and low for Rain Therapeutics Inc. Stock?
The 52-week high for Rain Therapeutics Inc. Stock is $8.50 and the 52-week low is $1.26.

What is the market capitalization of Rain Therapeutics Inc. Stock?
As of the Jun 30, 2026, the market capitalization of Rain Therapeutics Inc. is 18.701M.
Click to get the best stock tips daily for free!
ABOUT RAIN THERAPEUTICS INC.
Rain Therapeutics
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinica...
GOLDEN STAR
Ticker Change Signal Date
IIIV
$20.09
5.03% Jun 25
X
XMAX
$8.34
7.31% Jun 24
NMRK
$15.02
1.60% Jun 24
JLL
$299.78
4.44% Jun 24
CAG
$13.43
4.06% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE